Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Therapeutic advances in medical oncology, 14.2022, S. 1-13
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2022
- Creator
-
Stratmann, Jan A.
Timalsina, Radha
Atmaca, Akin
Rosery, Vivian
Frost, Nikolaj
Waller, Cornelius
Reinmuth, Niels
Rohde, Gernot Gerhard Ulrich
Saalfeld, Felix
Becker von Rose, Aaron
Acker, Fabian
Aspacher, Lukas Julian
Möller, Miriam
Sebastian, Martin
- DOI
-
10.1177/17588359221097191
- URN
-
urn:nbn:de:hebis:30:3-751202
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stratmann, Jan A.
- Timalsina, Radha
- Atmaca, Akin
- Rosery, Vivian
- Frost, Nikolaj
- Waller, Cornelius
- Reinmuth, Niels
- Rohde, Gernot Gerhard Ulrich
- Saalfeld, Felix
- Becker von Rose, Aaron
- Acker, Fabian
- Aspacher, Lukas Julian
- Möller, Miriam
- Sebastian, Martin
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2022
Other Objects (12)
Dopplersonographische Messung der Blutflussgeschwindigkeit in der Arteria mesenterica superior
Mobilisierung und Purging autologer Blutstammzellen als Voraussetzung der Hochdosis-Chemotherapie bei malignen Erkrankungen unter besonderer Berücksichtigung der chronischen myeloischen Leukämie
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Chemotherapie und febrile Neutropenie : Probleme und Konzepte
Chemotherapie und febrile Neutropenie - Probleme und Konzepte
Biosimilars in oncology: key role of nurses in patient education
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Effect of ABCG2, OCT1, and ABCB1 (MDR1) gene expression on treatment-free remission in a EURO-SKI subtrial
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Correction to: Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Dopplersonographische Messung der Blutflussgeschwindigkeit in der Arteria mesenterica superior
Mobilisierung und Purging autologer Blutstammzellen als Voraussetzung der Hochdosis-Chemotherapie bei malignen Erkrankungen unter besonderer Berücksichtigung der chronischen myeloischen Leukämie
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Chemotherapie und febrile Neutropenie : Probleme und Konzepte
Chemotherapie und febrile Neutropenie - Probleme und Konzepte
Biosimilars in oncology: key role of nurses in patient education
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Effect of ABCG2, OCT1, and ABCB1 (MDR1) gene expression on treatment-free remission in a EURO-SKI subtrial
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Correction to: Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Dopplersonographische Messung der Blutflussgeschwindigkeit in der Arteria mesenterica superior
Mobilisierung und Purging autologer Blutstammzellen als Voraussetzung der Hochdosis-Chemotherapie bei malignen Erkrankungen unter besonderer Berücksichtigung der chronischen myeloischen Leukämie
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Chemotherapie und febrile Neutropenie : Probleme und Konzepte
Chemotherapie und febrile Neutropenie - Probleme und Konzepte
Biosimilars in oncology: key role of nurses in patient education
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Effect of ABCG2, OCT1, and ABCB1 (MDR1) gene expression on treatment-free remission in a EURO-SKI subtrial
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants